HIGH

Cipla USA Recalls Cinacalcet Hydrochloride Tablets Over Nitrosamine Hazard

Cipla USA, Inc. recalled 15,744 bottles of Cinacalcet Hydrochloride Tablets on November 14, 2025. The recall follows the discovery of a nitrosamine impurity exceeding acceptable daily intake limits. Consumers should stop using the product immediately and consult healthcare providers.

Quick Facts at a Glance

Recall Date
November 14, 2025
Hazard Level
HIGH
Brands
CINACALCET, Cipla USA Inc.
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

Hazard Information

CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Cipla USA, Inc. or your healthcare provider for guidance. Notification method: Letter

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

About This Product

Cinacalcet Hydrochloride Tablets are prescribed for managing conditions related to parathyroid hormone levels, particularly in patients with chronic kidney disease. They help regulate calcium levels in the body, making them essential for certain patients.

Why This Is Dangerous

The presence of N-nitroso-cinacalcet in the tablets poses a health risk as it exceeds acceptable daily intake limits. This impurity can lead to serious health consequences if consumed regularly.

Industry Context

This recall is not part of a broader industry pattern.

Real-World Impact

Consumers may face health risks associated with the impurity in the recalled tablets. The urgency to stop use and seek alternatives may lead to disruptions in treatment for some patients.

Practical Guidance

How to identify if yours is affected

  1. Locate the lot number on your bottle of Cinacalcet Hydrochloride Tablets.
  2. Check if it matches Lot 5PB0164.
  3. Confirm the expiration date is January 31, 2027.

Where to find product info

The lot number and expiration date can typically be found on the label or bottom of the bottle.

What timeline to expect

Expect a refund or further instructions within 4-6 weeks following the recall notification.

If the manufacturer is unresponsive

  • Contact Cipla USA, Inc. directly via phone or email.
  • Document all correspondence regarding the recall.

How to prevent similar issues

  • Always check for recent recalls on medications before use.
  • Consult your healthcare provider about alternatives if a recall occurs.

Documentation advice

Keep receipts, correspondence with the manufacturer, and any medical records related to your use of the affected product.

Product Details

The recall involves Cinacalcet Hydrochloride Tablets, 60 mg, sold in 30-tablet bottles. The affected lot is Lot 5PB0164, which has an expiration date of January 31, 2027. The product was distributed nationwide in the United States.

Key Facts

  • Recall date: November 14, 2025
  • Quantity recalled: 15,744 bottles
  • Affected lot: Lot 5PB0164
  • Expiration date: January 31, 2027
  • Hazard: Nitrosamine impurity present

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
7/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product Details

Model Numbers
Lot 5PB0164
exp 1/31/2027
UPC Codes
69097-410
69097-411
69097-412
+3 more
Affected States
ALL
Report Date
December 17, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Vehicles & Parts
HIGH

Mazda CX-70 Recall 2025 for Powertrain Control Module Software May Lose Drive Power

Mazda North American Operations is recalling 2024 CX-90 and 2025 CX-70 SUVs sold through Mazda dealers. The PCM and ECM software can illuminate malfunction indicator lights and cause a loss of drive power, increasing crash risk. Owner notification letters were mailed December 19, 2024, and Mazda will reprogram the PCM and ECM at no charge.

Mazda
Loss of
Read more
Vehicles & Parts
HIGH

Nissan Kicks 2025 Certification Label Recall for GVWR/GAWR Errors (PD136, PMA47)

Nissan North America is recalling certain 2025 Nissan Kicks vehicles sold through Nissan dealers nationwide. The certification label may print incorrect GVWR and GAWR values, risking overload. Some SR trims with a 19-inch wheel package may display an incorrect wheel size on the label, and owners should contact their Nissan dealer to arrange replacement labels.

Nissan
An overloaded
Read more